Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Research topic
No spam. Unsubscribe anytime.
House committee adopts amendment to let medical‑marijuana fund support clinical trials research
Summary
Lawmakers adopted a Health and Human Services committee amendment to SB 12‑30 to allow monies from the medical marijuana fund to be used for grants supporting marijuana clinical trials; sponsor emphasized data‑driven practice and patient safety.
The Committee of the Whole recommended Senate Bill 12‑30 as amended, including a Health and Human Services committee amendment that restores language permitting the Medical Marijuana Fund to be used for grants to support marijuana clinical trials.
Representative Bliss, sponsor of the committee amendment, said the change reverts wording from "may" to "shall" so that monies in the DHS‑held Medical Marijuana Fund (drawn from medical marijuana card sales) can support research grants. Bliss framed the change as a patient‑safety and evidence‑based medicine issue: "It is time for us to pull our heads out of the sand to ensure the safety of those who choose to use marijuana or cannabis products for medical purposes," she said.
Representative Livingston had signaled intent to move an appropriations amendment but later withdrew it; the committee amendment and the bill as amended were recommended do pass and were advanced. Sponsor remarks emphasized ongoing research and the role of Senator Payne in driving funds toward clinical research.
Ending: SB 12‑30 advances as amended; the transcript records committee amendment adoption and the committee’s recommendation to report the bill do pass.
